Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 681 - 688 of 11439 results
Fighting for Access to Lifesaving HIV Medicine
November 16, 2023| Article| Viewpoint
Fighting for Access to Lifesaving HIV Medicine
November 16, 2023| Article| Viewpoint
FTC Advises Copyright Office on AI — AI: The Washington Report
November 16, 2023| Article| Viewpoint
How Some Law Firms Are Reimagining Succession Planning
November 15, 2023| News
State AGs Demand Action on Pulse Oximeter Inaccuracy as FDA's Efforts Lag
November 14, 2023| Blog| Viewpoint
FDA Delays Enforcement of MoCRA Facility Registration and Cosmetic Product Listing Requirements
November 13, 2023| Blog| Viewpoint
Client Corner: Meet Syntis Bio Co-founder and CEO Rahul Dhanda
November 10, 2023| Podcast| Viewpoint
Key Takeaways from the OIG’s New Comprehensive General Compliance Program Guidance
November 10, 2023| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.